{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:09:29Z","timestamp":1768068569054,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.eururo.2003.10.009","type":"journal-article","created":{"date-parts":[[2003,11,11]],"date-time":"2003-11-11T14:07:21Z","timestamp":1068559641000},"page":"240-244","source":"Crossref","is-referenced-by-count":36,"title":["Retrospective Analysis of Efficacy and Tolerability of Tolterodine in Children with Overactive Bladder"],"prefix":"10.1016","volume":"45","author":[{"given":"A.","family":"Raes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hoebeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Segaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Van Laecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dehoorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Vande Walle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2003.10.009_BIB1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0094-0143(21)01235-0","article-title":"The unstable bladder in childhood","volume":"7","author":"Bauer","year":"1980","journal-title":"Urol. Clin. North. Am."},{"key":"10.1016\/j.eururo.2003.10.009_BIB2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-5347(17)49468-7","article-title":"Urodynamic abnormalities in neurologically normal children with mycturition dysfunction","volume":"132","author":"Webster","year":"1984","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.10.009_BIB3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0022-5347(17)56417-4","article-title":"Association of urinary tract infection and reflux with inunhibited bladder contractions and voluntary sphincteric obstruction","volume":"122","author":"Koff","year":"1979","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.10.009_BIB4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-5347(17)60721-3","article-title":"Oxybutinin: a new drug with analgesic and anticholinergic properties","volume":"108","author":"Diokno","year":"1972","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.10.009_BIB5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0094-0143(21)00072-0","article-title":"Pharmacologic management of common urodynamic problems","volume":"6","author":"Milroy","year":"1979","journal-title":"Urol. Clin. North. Am."},{"key":"10.1016\/j.eururo.2003.10.009_BIB6","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0022-5347(17)56996-7","article-title":"Enuresis: principles of management and results of treatment","volume":"121","author":"Kass","year":"1979","journal-title":"J. Urol."},{"issue":"Suppl. 6A","key":"10.1016\/j.eururo.2003.10.009_BIB7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0090-4295(97)00599-2","article-title":"Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis","volume":"50","author":"Appell","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2003.10.009_BIB8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","article-title":"Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutinin in patients with an overactive bladder","volume":"81","author":"Abrams","year":"1998","journal-title":"Br. J. Urol."},{"issue":"Suppl. 2","key":"10.1016\/j.eururo.2003.10.009_BIB9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1464-410X.83.s2.10.x","article-title":"Treatment of the overactive bladder with tolterodine, a new muscarinic receptor antagonist","volume":"83","author":"Messelink","year":"1999","journal-title":"Br. J. Urol."},{"issue":"Suppl. 2","key":"10.1016\/j.eururo.2003.10.009_BIB10","first-page":"84","article-title":"Tissue distribution of tolterodine and its metabolites: low penetration into the central nervous system","volume":"37","author":"Nilvebrant","year":"2000","journal-title":"Eur. Urol."},{"key":"10.1016\/j.eururo.2003.10.009_BIB11","first-page":"226","article-title":"Tolterodine: selectivity for the bladder over effects on visual accommodation","volume":"163","author":"Chancellor","year":"2000","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.10.009_BIB12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-5347(05)66576-7","article-title":"Use of tolterodine in children with dysfunctional voiding: an initial report","volume":"165","author":"Munding","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.eururo.2003.10.009_BIB13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0090-4295(99)00477-X","article-title":"Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia","volume":"55","author":"Goessl","year":"2000","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.eururo.2003.10.009_BIB14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1464-410X.2001.00084.x","article-title":"Tthe overactive bladder in children: a potential future indication for tolterodine","volume":"87","author":"Hj\u00e4lmas","year":"2001","journal-title":"BJU Int."},{"key":"10.1016\/j.eururo.2003.10.009_BIB15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s001929970003","article-title":"Clinical efficacy and safety of tolterodine compared with oxybutinin and placebo with overactive bladder","volume":"10","author":"Drutz","year":"1999","journal-title":"Int. Urogynecol. J. Pelvic Floor Dysfunct."}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283803005335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283803005335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T09:51:33Z","timestamp":1704966693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283803005335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0302283803005335"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2003.10.009","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}